Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Nutcracker Therapeutics received early financing of $8.0M on 2017-11-28.
| Series | Round size | Date |
|---|---|---|
| Series B - Ursa Major Technologies | $15.5M | 07/2019 |
| Series A - Ursa Major Technologies | $8M | 11/2017 |
| Investors | Security type |
|---|---|
| Space Angels | Series B - Ursa Major Technologies |
| Dylan Taylor | Series B - Ursa Major Technologies |
| Alpha Edison | Series B - Ursa Major Technologies |
| Alsop Louie Partners | Series A - Ursa Major Technologies |
| Space Angels | Series A - Ursa Major Technologies |
| Dolby Family Ventures | Series A - Ursa Major Technologies |
Nutcracker Therapeutics's top competitor, Canopy, earned an annual revenue of $6.0M.
Nutcracker Therapeutics's smallest competitor is MOBO with revenue of $120.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Rocket Crafters | - | $290,000 | 1 | - |
| Canopy | - | $6.0M | 10 | - |
| Birdhouse | - | $5.2M | 25 | - |
| MOBO | - | $120,000 | 5 | - |
| Lookout | - | - | 376 | - |
| Token | - | $1.6M | 30 | - |
| The Fin Exploration Company | - | $1.6M | 45 | - |
| Finally | - | - | - | - |
| Metropolis | - | $1.6M | 50 | - |
| Hi5 | - | $2.9M | 7 | - |
Zippia gives an in-depth look into the details of Nutcracker Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Nutcracker Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Nutcracker Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Nutcracker Therapeutics. The data presented on this page does not represent the view of Nutcracker Therapeutics and its employees or that of Zippia.
Nutcracker Therapeutics may also be known as or be related to Nutcracker Therapeutics, Ursa Major Technologies, Ursa Major Technologies Inc and Ursa Major Technologies, Inc.